145 related articles for article (PubMed ID: 17622107)
1. Process optimization and characterization of poloxamer solid dispersions of a poorly water-soluble drug.
Shah TJ; Amin AF; Parikh JR; Parikh RH
AAPS PharmSciTech; 2007 Apr; 8(2):Article 29. PubMed ID: 17622107
[TBL] [Abstract][Full Text] [Related]
2. Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188.
Ghareeb MM; Abdulrasool AA; Hussein AA; Noordin MI
AAPS PharmSciTech; 2009; 10(4):1206-15. PubMed ID: 19862626
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro evaluation of solid dispersions of total flavones of Hippophae rhamnoides L.
Xie Y; Li G; Yuan X; Cai Z; Rong R
AAPS PharmSciTech; 2009; 10(2):631-40. PubMed ID: 19452282
[TBL] [Abstract][Full Text] [Related]
4. Effects of Polymers on the Drug Solubility and Dissolution Enhancement of Poorly Water-Soluble Rivaroxaban.
Choi MJ; Woo MR; Choi HG; Jin SG
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012748
[TBL] [Abstract][Full Text] [Related]
5. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.
Sammour OA; Hammad MA; Megrab NA; Zidan AS
AAPS PharmSciTech; 2006 Jun; 7(2):E55. PubMed ID: 16796372
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.
Liu C; Desai KG
Pharm Dev Technol; 2005; 10(4):467-77. PubMed ID: 16370176
[TBL] [Abstract][Full Text] [Related]
7. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68.
Chen Y; Zhang GG; Neilly J; Marsh K; Mawhinney D; Sanzgiri YD
Int J Pharm; 2004 Nov; 286(1-2):69-80. PubMed ID: 15501003
[TBL] [Abstract][Full Text] [Related]
8. Solubility enhancement of desloratadine by solid dispersion in poloxamers.
Kolašinac N; Kachrimanis K; Homšek I; Grujić B; Ðurić Z; Ibrić S
Int J Pharm; 2012 Oct; 436(1-2):161-70. PubMed ID: 22772487
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization and in vitro evaluation of solid dispersions containing docetaxel.
Chen J; Qiu L; Hu M; Jin Y; Han J
Drug Dev Ind Pharm; 2008 Jun; 34(6):588-94. PubMed ID: 18568908
[TBL] [Abstract][Full Text] [Related]
10. Effect of water-soluble carriers on dissolution characteristics of nifedipine solid dispersions.
Chutimaworapan S; Ritthidej GC; Yonemochi E; Oguchi T; Yamamoto K
Drug Dev Ind Pharm; 2000 Nov; 26(11):1141-50. PubMed ID: 11068687
[TBL] [Abstract][Full Text] [Related]
11. Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.
Zhao X; Liu X; Gan L; Zhou C; Mo J
Arch Pharm Res; 2011 Jun; 34(6):949-59. PubMed ID: 21725816
[TBL] [Abstract][Full Text] [Related]
12. Solid-state, triboelectrostatic and dissolution characteristics of spray-dried piroxicam-glucosamine solid dispersions.
Adebisi AO; Kaialy W; Hussain T; Al-Hamidi H; Nokhodchi A; Conway BR; Asare-Addo K
Colloids Surf B Biointerfaces; 2016 Oct; 146():841-51. PubMed ID: 27451373
[TBL] [Abstract][Full Text] [Related]
13. Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: investigating the relationship between physicochemical characteristics and dissolution behaviour.
Goddeeris C; Van den Mooter G
Eur J Pharm Sci; 2008 Sep; 35(1-2):104-13. PubMed ID: 18644442
[TBL] [Abstract][Full Text] [Related]
14. The Development and Optimization of Hot-Melt Extruded Amorphous Solid Dispersions Containing Rivaroxaban in Combination with Polymers.
Lee JH; Jeong HS; Jeong JW; Koo TS; Kim DK; Cho YH; Lee GW
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33800741
[TBL] [Abstract][Full Text] [Related]
15. Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions.
Medarević DP; Kachrimanis K; Mitrić M; Djuriš J; Djurić Z; Ibrić S
Pharm Dev Technol; 2016; 21(3):268-76. PubMed ID: 25582577
[TBL] [Abstract][Full Text] [Related]
16. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers.
Ahuja N; Katare OP; Singh B
Eur J Pharm Biopharm; 2007 Jan; 65(1):26-38. PubMed ID: 16962750
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical investigation of the solid dispersion systems of etoricoxib with poloxamer 188.
Karekar P; Vyas V; Shah M; Sancheti P; Pore Y
Pharm Dev Technol; 2009; 14(4):373-9. PubMed ID: 19552551
[TBL] [Abstract][Full Text] [Related]
18. Solubility and dissolution improvement of Rofecoxib using solid dispersion technique.
Rahamathulla M; Hv G; Rathod N
Pak J Pharm Sci; 2008 Oct; 21(4):350-5. PubMed ID: 18930854
[TBL] [Abstract][Full Text] [Related]
19. Effect of a melt agglomeration process on agglomerates containing solid dispersions.
Vilhelmsen T; Eliasen H; Schaefer T
Int J Pharm; 2005 Oct; 303(1-2):132-42. PubMed ID: 16139973
[TBL] [Abstract][Full Text] [Related]
20. Formulation and in vivo hypoglycemic effect of glipizide solid dispersion.
Patel GC; Asodaria KV; Patel HP; Shah DR
Curr Drug Deliv; 2012 Jul; 9(4):395-404. PubMed ID: 22640037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
